Skip to main content
Announcement | Center for Nanoscale Materials

Current CNM User Facility Access

January 21, 2022: Wearable proximity devices 

Argonne and the Center for Nanoscale Materials (CNM) are committed to the health and safety of each individual who works at and visits our campus. COVID-19 protocols remain in place at this time.

CNM users who visit us in person will be issued proximity devices for the duration of their time on campus. These wearable devices will be distributed by Hua Chen, CNM Environment, Safety, and Health Coordinator, and should be returned before you conclude your approved time on campus. These small, lightweight wearable devices are used to provide reliable contact tracing information to Argonne clinicians. The devices detect and record device-to-device interaction. They do not track location or collect any personally identifiable information.

November 22, 2021: Argonne requires vaccinations or employer exemptions for CNM user site access

Argonne National Laboratory is committed to helping protect the health and safety of those who visit our site. Argonne and the Center for Nanoscale Materials (CNM) remain in a limited state of operations. However, starting November 22, 2021, Argonne will change its requirements for site access and all CNM users will only be able to enter the laboratory site if they: 

  • Provide proof of COVID-19 vaccination; or 
  • Provide proof that they have received an exemption from their employer or home institution, allowing them to remain unvaccinated. In this case, users will need to provide proof that they are enrolled in a COVID-19 screening program through their employer that tests at least weekly, or provide a negative result from a COVID-19 test conducted within the last 72 hours. 

This change means that unvaccinated users will no longer be able to access the Argonne campus or the CNM facility with only a negative COVID-19 test result.

The laboratory will continue to update its site access policies based on the evolution of the COVID-19 pandemic.

More detailed instructions are available within this announcement.

November 11, 2021: CNM user operations update

Argonne National Laboratory remains in Limited Operations. Principal Investigators (PIs) are notified when the work is completed using remote operations, or as newer UWAs are activated or identified. Accepted proposals that have not yet begun, as evidenced by a UWA start date, are being kept in a pending status. 

Currently, the CNM user program is supporting: 

  • Mail-in/remote operation/participation for many capabilities. Tools available remotely are indicated by an asterisk in the list of capabilities at this link.
  • Remote access to the supercomputing cluster, Carbon, and programs developed by CNM’s Theory and Modeling Group.
  • Mail-out programs for select samples, depositions, fabrications and other select capabilities
  • Visit requests that require user presence to conduct experiments at the CNM can be sent either through (a) a user’s proposal dashboard if you are not an Argonne employee or (b) the Visit Management System for users who are Argonne employees. An existing or pending user work approval (UWA) on an allocated proposal is required. For the safety of everyone at the CNM, there will be repercussions if we determine you are in a CNM facility without a visit request. For the first occurrence there will be a loss of one month of access, for the second occurrence there will be a loss of two months and a third occurrence will result in loss for the duration of the user work approval (UWA). 
  • Off-hours access for authorized users who are Argonne employees and who do not hold a student status (graduate, undergraduate or high school).

As the public health situation improves, Argonne will eventually move to the next stages of operations. The health and safety of our employees, users, students and visitors remains our top priority. As the public health situation improves, Argonne will eventually move to subsequent phases, which will bring more user activity back onsite. We will continue to monitor and adapt to changing conditions onsite, in the surrounding communities, in our state and nationwide.

July 29, 2021: Face coverings for all people on site

To reduce the risk of being infected with the COVID-19 Delta variant and spreading it to others, the Centers for Disease Control and Prevention (CDC) issued guidance for fully vaccinated people to wear a face covering indoors in public if they are in an area of substantial or high transmission.

The U.S. Department of Energy announced that all people, including those who are vaccinated, must wear face coverings when in DOE buildings and leased spaces in areas of substantial or high community transmission.

DuPage and Will counties, two of the three we monitor as part of Argonne’s region, are experiencing substantial community transmission. As a result, effective Thursday, July 29, 2021, 12 a.m. Central Time, face coverings are again required at all Argonne facilities, regardless of an individual’s vaccination status.

You must wear a face covering in all public and work areas within a building (e.g., shared offices and labs, hallways, elevators, restrooms). Face coverings are required in all face-to-face meetings and at security checkpoints (though security may ask you to lower your face covering to verify identity). Face coverings are also required inside government-owned vehicles when another person is in the vehicle. You may remove your face covering when alone in an enclosed space or when necessary to eat, provided you are six feet away from other people. Face coverings are required outdoors only when you are within six feet of another person.

As a reminder, if you are experiencing any COVID-19-like symptoms, do not come on site, even if you are fully vaccinated. Symptoms, and their intensity, vary greatly from person to person. Though vaccines provide strong protection against severe illness, hospitalization, and death, breakthrough cases may cause mild cases that allow for person-to-person transmission.

Our priority is to keep people safe so Argonne can continue to deliver on its scientific mission through the pandemic. We appreciate your continued adoption of COVID-19 safety protocols, especially as we adapt them to respond to changing levels of risk.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://​ener​gy​.gov/​s​c​ience.